Bemarituzumab - HY-P99010
Nur noch %1 verfügbar
Catalog #
HY-P99010
Ab
207,00 €
Bemarituzumab is a humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has antitumor activity against gastric and breast cancer[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99010/Bemarituzumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-Kinase/protease |
| CAS | 1952272-74-0 |
| Storage | Store at -80°C for 2 years |
| MWT | (143.86 kDa) |
| Solubility | H2O |
| Clinical Information | Phase 3 |
| Target | FGFR |
| Application: | Cancer-Kinase/protease |
|---|